Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Clinical Trials Market Analysis and Forecast to 2033: By Phase (Phase I, Phase Ii, Phase Iii, Phase Iv, Preclinical), Design (Interventional Trials, Observational Trials, Expanded Access Trials), Indication (Oncology, Cardiology, Neurology, Infectious Diseases, Gastroenterology, Immunology, Respiratory, Endocrinology, Dermatology, Ophthalmology), Study Type (Randomized Controlled Trials, Non-Randomized Controlled Trials, Adaptive Trials, Single-Arm Trials), Service Type (Clinical Trial Management, Patient Recruitment, Laboratory Services, Data Management), End User (Pharmaceutical Companies, Contract Research Organizations, Academic Institutions, Medical Device Manufacturers, Public Health Organizations), and Region
... Respiratory, Endocrinology, Dermatology, Ophthalmology), Study Type (Randomized Controlled Trials, Non-Randomized Controlled Trials, Adaptive Trials, Single-Arm Trials), Service Type (Clinical Trial Management, Patient Recruitment, Laboratory Services, Data Management), End User (Pharmaceutical Companies, Contract Research Organizations, Academic ... Read More
-
Antisense & RNAi Therapeutics – A Global Market Overview
... utilizes synthetic nucleic acids called antisense oligonucleotides (ASOs) that bind to specific messenger RNA (mRNA) sequences, effectively silencing disease-associated genes. RNAi employs double-stranded RNA (dsRNA) to produce small interfering RNA (siRNA) and microRNA (miRNA) that ... Read More
-
Situation Awareness System (SAS) Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... of around 7.1% during 2025-2034. This report on global situation awareness system (SAS) market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a ... Read More
-
Glycogen Storage Disorders (GSD): Competitive Landscape
... are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast. Most of the marketed drugs for GSD are enzyme replacement therapies. The Phase III pipeline consists of two drugs, with seven drugs in Phase ... Read More
-
Global Benzodiazepine Drugs Market Size study, by Drug Type (Alprazolam, Clonazepam, Diazepam, Lorazepam, Others), by Application (Anxiety, Insomnia, Alcohol Withdrawal, Seizures, Others), by Time of Action (Ultra-short Acting, Short Acting, Long Acting), by End-user (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2022-2032
... Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2022-2032 The Global Benzodiazepine Drugs Market is valued at approximately USD 2.2 billion in 2023 and is anticipated to grow with a steady growth rate of 3.5% ... Read More
-
Consumer Health in Australia
... suffering, as some consumers are also being forced to reduce spending on essentials such as groceries to keep up with bills and debts. In general, consumer health is a resilient industry. Categories such as analgesics ... Read More
-
Sleep Aids in Australia
... remains evident in Australia with many, particularly consumers aged 18-30 years, seeking help for anxiety, poor sleep quality and unhealthy sleep habits. In addition, the review period has seen surging inflation rates, higher interest rates, ... Read More
-
Dietary Supplements in Australia
... be attributable partly to price-driven growth, dietary supplements continues to grow in retail volume terms across much of the category. This highlights that spending on dietary supplements has been maintained amidst a difficult economic climate ... Read More
-
Analgesics in Australia
... 2023, the TGA has given manufacturers and retailers until February 2025 to adjust to the new measures, which have been driven by the need for a harm reduction approach to curb the high rates of ... Read More
-
Paediatric Consumer Health in Australia
... products, the move has impacted chewable tablet formats. Announced by the TGA in May 2023, the new restrictions on acetaminophen include: reducing the maximum size of packs available for general sale (such as through supermarkets ... Read More
-
Global Consumer Healthcare Market Size Study, by Product (OTC Pharmaceuticals, Dietary Supplements), by Distribution Channel (Offline, Online), and Regional Forecasts 2022-2032
... is anticipated to expand at a robust CAGR of 6.78% over the forecast period from 2024 to 2032. Consumer healthcare plays a pivotal role in empowering individuals to manage their health and well-being through accessible ... Read More
-
Global OTC Anti-Infective Products Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites. According to our ... Read More
-
Newron Pharmaceuticals SpA (NWRN) - Financial and Strategic SWOT Analysis Review
... The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate ... Read More
-
Cleanroom Technologies Market by Product (HEPA Filters, HVAC, Laminar Air Flow Systems, Safety/Cleaning Consumables, Controls), Type (Standard, Modular (Hardwall, Softwall), Mobile), End User (Pharmaceutical, Biotechnology) - Global Forecast to 2029
... is projected to reach USD 8.8 billion in 2024 and is projected to reach USD 12.3 billion by 2029, at a CAGR of 6.9% during the forecast period. The most significant driver is the growing ... Read More
-
Global High Volume Dispensing Systems Market 2024-2028
... the high volume dispensing systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Naltrexone Market Size Study, by Type (25 mg, 50 mg), by Application (Opioid Independence, Alcohol Independence), by End-User (Hospitals & Clinics, Rehabilitation Centers, Wellness Centers, Others) and Regional Forecasts 2022-2032
... is valued at approximately USD 21.0 billion in 2023 and is anticipated to grow with a steady growth rate of more than 3.6% over the forecast period 2024-2032. Naltrexone, widely known under the brand name ... Read More
-
Global Home Healthcare Market Size Study, by Product (Therapeutic Products, Testing, Screening, and Monitoring Products, Mobility Care Products), by Service (Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, Pregnancy Care), by Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases & Hypertension, Pregnancy, Wound Care, Diabetes, Hearing Disorders, Other Indications), and Regional Forecasts 2022-2032
... Care), by Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases & Hypertension, Pregnancy, Wound Care, Diabetes, Hearing Disorders, Other Indications), and Regional Forecasts 2022-2032 Global Home Healthcare Market is valued at approximately USD 250.0 billion ... Read More
-
CASI Pharmaceuticals Inc (CASI) - Financial and Strategic SWOT Analysis Review
... The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate ... Read More
-
Lumos Pharma Inc (LUMO) - Financial and Strategic SWOT Analysis Review
... The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate ... Read More
-
Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review
... has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that ... Read More
-
Global Stem Cell Therapy for Osteoarthritis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... progressive to joint stiffness, swelling, pain, and loss of mobility. The prevalence rate of OA is extremely high, affecting more than 250 million people worldwide. With increases in the aging and obese populations, the prevalence ... Read More
-
Digestive Remedies in Australia
... impacted consumer spending – in conjunction with higher interest rates and the rapid rise in the cost of living. Consumer Price Index (CPI) indicators reveal that spending on health, including pharmaceuticals, rose by 5.3% year-on-year ... Read More
-
Dermatologicals in Australia
... February 2024), skin conditions (including skin rashes, eczema and psoriasis) had a moderate to severe impact on everyday life for 49% of respondents in Australia, the highest rate on record since tracking began in 2019 ... Read More
-
NRT Smoking Cessation Aids in Australia
... Institute of Health and Welfare’s National Drug Strategy Household Survey 2022-2023, fewer than 10% of people in Australia over 14 years of age smoked daily, while the use of e-vapour products tripled between 2019 and ... Read More
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about ... Read More
Research Assistance
